Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2000
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026242A2 Dna replication-regulating genes, antibodies thereto and diagnostic applications thereof
05/11/2000WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases
05/11/2000WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
05/11/2000WO2000026233A1 Selective toxicity of amino-terminal modified rnase a superfamily polypeptides
05/11/2000WO2000026230A1 Low allergenic protein variants
05/11/2000WO2000026228A1 Gene and protein for regulation of cell death
05/11/2000WO2000026227A1 Ldl related protein and uses thereof
05/11/2000WO2000026188A1 Cycloheximide derivatives which influence the regeneration of neural tissue
05/11/2000WO2000025839A1 Method for preparing bone material
05/11/2000WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination
05/11/2000WO2000025826A1 Lactone bearing absorbable polymers
05/11/2000WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000WO2000025811A2 Multicomponent meningococcal vaccine
05/11/2000WO2000025809A1 Compositions comprising notch receptor manipulating agents
05/11/2000WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000WO2000025806A1 Method for weight control
05/11/2000WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
05/11/2000WO2000025804A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
05/11/2000WO2000025803A1 Betacellulin protein-containing preparations
05/11/2000WO2000025798A1 Treatment of parkinson's disease with oligonucleotides
05/11/2000WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025784A1 Method for improving the pharmacokinetics of tipranavir
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025761A1 Capsules with porous mineral cortex
05/11/2000WO2000025745A2 Irrigation solution and method for inhibition of pain and inflammation
05/11/2000WO2000025725A2 Functional antagonists of hedgehog activity
05/11/2000WO2000025601A1 Energetic rehydration fluid composition in particular for young animals no longer able to digest milk normally
05/11/2000WO2000025578A2 Methods for cloning animals
05/11/2000WO2000018783B1 Mammaglobin, a secreted mammary-specific breast cancer protein
05/11/2000WO2000017234A8 Purification of fibrinogen from milk by use of cation exchange chromatography
05/11/2000WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
05/11/2000WO2000009150A3 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
05/11/2000WO2000008158A3 Molecules designated ldcam
05/11/2000WO2000008156A3 Dna replication- and repair-associated proteins
05/11/2000WO2000008146A3 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents
05/11/2000WO2000008015A3 Fsh mimetics for the treatment of infertility
05/11/2000WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
05/11/2000WO2000007565A3 Methods of ophthalmic administration
05/11/2000WO2000007543A3 Conjugates targeted to the interleukin-2 receptors
05/11/2000WO2000006189A3 Conversion of naturally-occurring quinones to quinone derivatives by macrophage migration inhibition factor and uses thereof
05/11/2000WO2000006087A3 Uncoupling protein-2(hcp2): compositions and methods of use
05/11/2000WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
05/11/2000WO1999054460A3 Human nucleic acid sequences of normal bladder tissue
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000DE19851675A1 Menschliche Interleukin-10 Mutantenproteine Human interleukin-10 mutant proteins
05/11/2000DE19847364C1 Tumor-Protein Tumor protein
05/11/2000CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/11/2000CA2350233A1 Transgenic and cloned mammals
05/11/2000CA2350212A1 Treatment of parkinson's disease with oligonucleotides
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349758A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
05/11/2000CA2349674A1 Capsules with porous mineral cortex
05/11/2000CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000CA2349586A1 Coenzyme a-utilizing enzymes
05/11/2000CA2349477A1 Regulator of notch signaling activity
05/11/2000CA2349417A1 Ikaros isoforms and mutants
05/11/2000CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000CA2349346A1 Lactone bearing absorbable polymers
05/11/2000CA2349331A1 Multicomponent meningococcal vaccine
05/11/2000CA2349212A1 Myosin heavy chain homolog
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2348938A1 Low allergenic protein variants
05/11/2000CA2348822A1 Glycosylated proteins having reduced allergenicity
05/11/2000CA2348777A1 Rotavirus subunit vaccine
05/11/2000CA2348774A1 Therapeutic antiangiogenic endostatin compositions
05/11/2000CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases
05/11/2000CA2348745A1 Dna molecules encoding muc-1 and use thereof in tumor vaccination
05/11/2000CA2348714A1 Energetic rehydration fluid composition in particular for young animals no longer able to digest milk normally
05/11/2000CA2348475A1 Tuberculosis diagnostic test
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2348292A1 Betacellulin protein-containing preparation
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347119A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2346131A1 Method for improving the pharmacokinetics of tipranavir
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/10/2000EP0999270A1 Method of regulating SMN gene expression
05/10/2000EP0999269A1 CDNA sequence and genomic organization for a 59.4 kDa neuronal-specific 7 transmembrane protein (pNEU60)
05/10/2000EP0999268A1 New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
05/10/2000EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/10/2000EP0999219A2 Novel heparin binding peptides
05/10/2000EP0998942A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
05/10/2000EP0998941A1 Drugs containing as the active ingredient midkine or inhibitors thereof
05/10/2000EP0998940A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
05/10/2000EP0998926A1 Oral preparation comprising S-(3-hydroxypropyl)-L-cysteine
05/10/2000EP0998916A1 Medicinal compositions for application to mucosa
05/10/2000EP0998585A1 SCREENING METHODS USING AN ATPASE PROTEIN FROM A VIRUS OF THE $i(FLAVIVIRIDAE) FAMILY
05/10/2000EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
05/10/2000EP0998578A1 Sel-10 AND USES THEREOF
05/10/2000EP0998577A1 Conjugates of transporter peptides and nucleic acid analogs, and their use
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998573A2 Fusion proteins with an immunoglobulin hinge region linker
05/10/2000EP0998572A2 Aggrecan degrading metallo proteases
05/10/2000EP0998570A1 Recombinant lysostaphin analogs
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998568A1 Mutant having uracil phosphoribosyl transferase activity
05/10/2000EP0998565A1 Interleukin-3 gene therapy for cancer
1 ... 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 ... 3163